Carta al Director
Vacunación SARS-CoV-2 y tratamiento con radiofármacos: documento del Grupo de Trabajo de Endocrinología de la SEMNIM
SARS-Cov-2 vaccination and metabolic radionuclide therapy: document of the SEMNIM Endocrinology Working Group
Leído
1779
Vecesse ha leído el artículo
53
Total PDF
1726
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 10 | 17 | 0 | 17 |
| 2025 9 | 19 | 0 | 19 |
| 2025 8 | 20 | 0 | 20 |
| 2025 7 | 14 | 0 | 14 |
| 2025 6 | 23 | 0 | 23 |
| 2025 5 | 13 | 0 | 13 |
| 2025 4 | 19 | 0 | 19 |
| 2025 3 | 21 | 0 | 21 |
| 2025 2 | 23 | 0 | 23 |
| 2025 1 | 14 | 0 | 14 |
| 2024 12 | 12 | 0 | 12 |
| 2024 11 | 11 | 0 | 11 |
| 2024 10 | 22 | 0 | 22 |
| 2024 9 | 29 | 0 | 29 |
| 2024 8 | 19 | 0 | 19 |
| 2024 7 | 18 | 0 | 18 |
| 2024 6 | 34 | 0 | 34 |
| 2024 5 | 39 | 0 | 39 |
| 2024 4 | 36 | 0 | 36 |
| 2024 3 | 46 | 2 | 48 |
| 2024 2 | 43 | 0 | 43 |
| 2024 1 | 58 | 0 | 58 |
| 2023 12 | 46 | 2 | 48 |
| 2023 11 | 49 | 0 | 49 |
| 2023 10 | 68 | 1 | 69 |
| 2023 9 | 40 | 1 | 41 |
| 2023 8 | 47 | 0 | 47 |
| 2023 7 | 34 | 0 | 34 |
| 2023 6 | 48 | 0 | 48 |
| 2023 5 | 37 | 0 | 37 |
| 2023 4 | 23 | 0 | 23 |
| 2023 3 | 29 | 0 | 29 |
| 2023 2 | 41 | 0 | 41 |
| 2022 1 | 43 | 0 | 43 |
| 2022 12 | 33 | 0 | 33 |
| 2022 11 | 34 | 0 | 34 |
| 2022 10 | 37 | 0 | 37 |
| 2022 9 | 34 | 2 | 36 |
| 2022 8 | 36 | 2 | 38 |
| 2022 7 | 20 | 0 | 20 |
| 2022 6 | 23 | 0 | 23 |
| 2022 5 | 23 | 2 | 25 |
| 2022 4 | 16 | 1 | 17 |
| 2022 3 | 28 | 2 | 30 |
| 2022 2 | 10 | 2 | 12 |
| 2021 1 | 15 | 0 | 15 |
| 2021 12 | 49 | 6 | 55 |
| 2021 11 | 108 | 0 | 108 |
| 2021 10 | 77 | 8 | 85 |
| 2021 9 | 125 | 12 | 137 |
| 2021 8 | 3 | 8 | 11 |
| 2021 7 | 0 | 2 | 2 |
Mostrar todo
